Published in Int J Cardiol on March 21, 2007
"In-house" pharmacological management for computed tomography coronary angiography: heart rate reduction, timing and safety of different drugs used during patient preparation. Eur Radiol (2009) 1.06
Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study. Clin Cardiol (2011) 0.86
Impact of preload changes on positive and negative left ventricular dP/dt and systolic time intervals: preload changes on left ventricular function. Indian Heart J (2012) 0.79
The effect of radiographic contrast media on reperfusion injury in the isolated rat heart. Korean Circ J (2014) 0.75
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet (2007) 7.61
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA (2002) 4.94
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol (2009) 4.82
Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol (2005) 4.05
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med (2005) 3.60
Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation (2007) 3.40
Coronary collateral function long after drug-eluting stent implantation. J Am Coll Cardiol (2006) 3.07
Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation (2003) 2.97
Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv (2011) 2.67
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol (2005) 2.47
Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation (2009) 2.47
Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol (2004) 2.30
Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol (2005) 2.19
Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study. Circulation (2012) 2.17
Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J Am Coll Cardiol (2010) 2.16
Collateral-flow measurements in humans by myocardial contrast echocardiography: validation of coronary pressure-derived collateral-flow assessment. Eur Heart J (2005) 2.12
25 years of coronary angioplasty: almost a fairy tale. Lancet (2003) 2.09
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ (2008) 2.09
Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA (2006) 2.06
Novel sutureless telescoping anastomosis revascularization technique of supra-aortic vessels to simplify combined open endovascular procedures in the treatment of aortic arch pathologies. J Vasc Surg (2010) 2.04
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial. Circulation (2013) 2.03
Clinical relevance of coronary angiography at the time of percutaneous closure of a patent foramen ovale. Catheter Cardiovasc Interv (2007) 2.03
Is alcohol ablation of the septum associated with recurrent tachyarrhythmias? Swiss Med Wkly (2007) 2.01
CT angiography at 24 months demonstrates durability of EVAR with the use of chimney grafts for pararenal aortic pathologies. J Endovasc Ther (2013) 1.94
Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow-up study in 403 patients with coronary artery disease. J Am Coll Cardiol (2002) 1.92
Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation (2007) 1.90
Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol (2011) 1.86
Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol (2008) 1.84
Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries? Circulation (2003) 1.83
Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J (2005) 1.81
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol (2007) 1.81
Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology (2005) 1.76
Coronary collateral perfusion in patients with coronary artery disease: effect of metoprolol. Eur Heart J (2004) 1.73
Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else! Circulation (2008) 1.72
Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol (2005) 1.71
Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol (2010) 1.71
Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J (2013) 1.70
Raw data-based iterative reconstruction in body CTA: evaluation of radiation dose saving potential. Eur Radiol (2011) 1.63
Amplatzer left atrial appendage occlusion: single center 10-year experience. Catheter Cardiovasc Interv (2013) 1.59
Percutaneous coronary interventions in Europe 1992-2001. Eur Heart J (2004) 1.58
Life-threatening complication after right renal extracorporeal shock wave lithotripsy: large hepatic haematoma requiring embolisation of the right hepatic artery. Eur Urol (2007) 1.57
Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology (2005) 1.57
Complete endovascular renal and visceral artery revascularization and exclusion of a ruptured type IV thoracoabdominal aortic aneurysm. J Endovasc Ther (2010) 1.55
Late coronary stent thrombosis. Circulation (2007) 1.54
Endovascular treatment of Angio-Seal-related limb ischemia--primary results and long-term follow-up. Catheter Cardiovasc Interv (2010) 1.54
Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. J Am Coll Cardiol (2007) 1.54
Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg (2004) 1.54
Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. AJR Am J Roentgenol (2003) 1.53
Midterm outcome of endovascular repair of ruptured abdominal aortic aneurysms. J Vasc Surg (2005) 1.52
Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. Eur Heart J (2012) 1.52
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. JACC Cardiovasc Interv (2012) 1.49
Chimney and periscope grafts observed over 2 years after their use to revascularize 169 renovisceral branches in 77 patients with complex aortic aneurysms. J Endovasc Ther (2013) 1.48
Transient apical ballooning syndrome--clinical characteristics, ballooning pattern, and long-term follow-up in a Swiss population. Int J Cardiol (2008) 1.48
Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Catheter Cardiovasc Interv (2007) 1.48
Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment. Catheter Cardiovasc Interv (2009) 1.47
Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size. JACC Cardiovasc Interv (2009) 1.47
Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents. Am Heart J (2012) 1.47
MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. J Magn Reson Imaging (2003) 1.46
Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol (2012) 1.44
Double-vessel coronary stenting via 5 French diagnostic catheters. Catheter Cardiovasc Interv (2011) 1.44
Extent and distribution of calcification of both the aortic annulus and the left ventricular outflow tract predict aortic regurgitation after transcatheter aortic valve replacement. EuroIntervention (2014) 1.44
Does the beta-blocker nebivolol increase coronary flow reserve? Cardiovasc Drugs Ther (2007) 1.43
Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv (2010) 1.42
All comers 5 French transfemoral percutaneous coronary intervention without sheath. Catheter Cardiovasc Interv (2011) 1.42
The heart of patients with aortic aneurysms: evidence from cardiac computed tomography. Interact Cardiovasc Thorac Surg (2009) 1.41
Late cardiac tamponade after percutaneous closure of a patent foramen ovale. Eur J Echocardiogr (2005) 1.41
Sirolimus versus paclitaxel coronary stents in clinical practice. Catheter Cardiovasc Interv (2011) 1.41
Aortoiliac and lower extremity arteries assessed with 16-detector row CT angiography: prospective comparison with digital subtraction angiography. Radiology (2005) 1.40
Subtraction CT angiography of the lower limbs: a new technique for the evaluation of acute arterial occlusion. AJR Am J Roentgenol (2004) 1.40
Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients. Catheter Cardiovasc Interv (2009) 1.40
Clinical use of temporary percutaneous left ventricular assist devices. Catheter Cardiovasc Interv (2011) 1.40
Influence of frequency of stenting on acute and one-year follow-up results. J Invasive Cardiol (2003) 1.39
Novel femoral artery puncture closure device in patients undergoing interventional and diagnostic cardiac procedures. J Invasive Cardiol (2002) 1.38
Prognostic value of early exercise testing after coronary stent implantation. Am J Cardiol (2008) 1.38
Periscope endograft technique to revascularize the left subclavian artery during thoracic endovascular aortic repair. J Endovasc Ther (2013) 1.38
Diagnostic performance of a non-contrast-enhanced magnetic resonance imaging protocol for potential living related kidney donors. Acad Radiol (2013) 1.38
Port-a-Cath perforation of the right atrium closed with an amplatzer ASD occluder. Catheter Cardiovasc Interv (2007) 1.38
Device-less patent foramen ovale closure by radiofrequency thermal energy. Swiss Med Wkly (2008) 1.37
10 years of emergency endovascular aneurysm repair for ruptured abdominal aortoiliac aneurysms: lessons learned. Ann Surg (2009) 1.37
Aorto-right ventricular fistula after transfemoral aortic valve implantation. J Invasive Cardiol (2010) 1.25
Iatrogenic left main coronary artery dissection: incidence, classification, management, and long-term follow-up. Am Heart J (2010) 1.23
Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention (2011) 1.22
Multiple periscope and chimney grafts to treat ruptured thoracoabdominal and pararenal aortic aneurysms. J Endovasc Ther (2011) 1.20
Segmental arterial mediolysis: CTA findings at presentation and follow-up. AJR Am J Roentgenol (2006) 1.19
Percutaneous management of vascular complications in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv (2012) 1.19
Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations. J Vasc Interv Radiol (2004) 1.19
Impact of weather and climate on the incidence of acute coronary syndromes. Int J Cardiol (2006) 1.16
Patent foramen ovale, guilty but only as a gang member and for a lesser crime. J Am Coll Cardiol (2005) 1.15
Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation (2012) 1.12
Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J (2011) 1.12